Terms: = Cervical cancer AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990
5 results:
1. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM
Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988
[TBL] [Abstract] [Full Text] [Related]
2. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
[TBL] [Abstract] [Full Text] [Related]
3. Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma.
O'Leary JJ; Landers RJ; Crowley M; Healy I; Kealy WF; Hogan J; Doyle CT
J Clin Pathol; 1997 Nov; 50(11):896-903. PubMed ID: 9462237
[TBL] [Abstract] [Full Text] [Related]
4. CUMC-6, a new diploid human cell line derived from a squamous carcinoma of the uterine cervix.
Kim JW; Lee CG; Cho YH; Kim JH; Kim SJ; Kim HK; Park TC; Song SK; Namkoong SE
Gynecol Oncol; 1996 Aug; 62(2):230-40. PubMed ID: 8751555
[TBL] [Abstract] [Full Text] [Related]
5. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
Mitra AB; Murty VV; Pratap M; Sodhani P; Chaganti RS
Cancer Res; 1994 Feb; 54(3):637-9. PubMed ID: 7905784
[TBL] [Abstract] [Full Text] [Related]
